» Articles » PMID: 8159756

A Tumor Suppressor Locus Within 3p14-p12 Mediates Rapid Cell Death of Renal Cell Carcinoma in Vivo

Overview
Specialty Science
Date 1994 Apr 12
PMID 8159756
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

High frequency loss of alleles and cytogenetic aberrations on the short arm of chromosome 3 have been documented in renal cell carcinoma (RCC). Potentially, three distinct regions on 3p could encode tumor suppressor genes involved in the genesis of this cancer. We report that the introduction of a centric fragment of 3p, encompassing 3p14-q11, into a highly malignant RCC cell line resulted in a dramatic suppression of tumor growth in athymic nude mice. Another defined deletion hybrid contained the region 3p12-q24 of the introduced human chromosome and failed to suppress tumorigenicity. These data functionally define a tumor suppressor locus, nonpapillary renal carcinoma-1 (NRC-1), within 3p14-p12, the most proximal region of high frequency allele loss in sporadic RCC as well as the region containing the translocation breakpoint in familial RCC. Furthermore, we provide functional evidence that NRC-1 controls the growth of RCC cells by inducing rapid cell death in vivo.

Citing Articles

Modeling clear cell renal cell carcinoma and therapeutic implications.

Wolf M, Rathmell W, Beckermann K Oncogene. 2020; 39(17):3413-3426.

PMID: 32123314 PMC: 7194123. DOI: 10.1038/s41388-020-1234-3.


Identification of genetic variants predictive of early onset pancreatic cancer through a population science analysis of functional genomic datasets.

Chen J, Wu X, Huang Y, Chen W, Brand R, Killary A Oncotarget. 2016; 7(35):56480-56490.

PMID: 27486767 PMC: 5302929. DOI: 10.18632/oncotarget.10924.


DEAR1, a novel tumor suppressor that regulates cell polarity and epithelial plasticity.

Chen N, Balasenthil S, Reuther J, Killary A Cancer Res. 2014; 74(20):5683-9.

PMID: 25261235 PMC: 4214267. DOI: 10.1158/0008-5472.CAN-14-1171.


VGLL3 expression is associated with a tumor suppressor phenotype in epithelial ovarian cancer.

Gambaro K, Quinn M, Wojnarowicz P, Arcand S, de Ladurantaye M, Barres V Mol Oncol. 2013; 7(3):513-30.

PMID: 23415753 PMC: 5528482. DOI: 10.1016/j.molonc.2012.12.006.


Experimental in vivo and in vitro treatment with a new histone deacetylase inhibitor belinostat inhibits the growth of pancreatic cancer.

Dovzhanskiy D, Arnold S, Hackert T, Oehme I, Witt O, Felix K BMC Cancer. 2012; 12:226.

PMID: 22681698 PMC: 3407493. DOI: 10.1186/1471-2407-12-226.


References
1.
Shimizu M, Yokota J, Mori N, Shuin T, Shinoda M, Terada M . Introduction of normal chromosome 3p modulates the tumorigenicity of a human renal cell carcinoma cell line YCR. Oncogene. 1990; 5(2):185-94. View

2.
Latif F, Tory K, Gnarra J, Yao M, Duh F, Orcutt M . Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 1993; 260(5112):1317-20. DOI: 10.1126/science.8493574. View

3.
Ogawa O, Kakehi Y, Ogawa K, Koshiba M, Sugiyama T, Yoshida O . Allelic loss at chromosome 3p characterizes clear cell phenotype of renal cell carcinoma. Cancer Res. 1991; 51(3):949-53. View

4.
Southern E . Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975; 98(3):503-17. DOI: 10.1016/s0022-2836(75)80083-0. View

5.
Cohen A, Li F, Berg S, Marchetto D, Tsai S, Jacobs S . Hereditary renal-cell carcinoma associated with a chromosomal translocation. N Engl J Med. 1979; 301(11):592-5. DOI: 10.1056/NEJM197909133011107. View